Start 30 days free, no card. Full Pro access for a month, then decide. Start free
Loading
Start 30 days free, no card. Full Pro access for a month, then decide. Start free
Calendar quarter Q2 2026Earnings call Aug 5, 2026 · most recent call
CVS’s newest analyzed quarter is part of Tellvest Pro: its score, breakdown, narrative and analyst Q&A. Every prior quarter is free.
Sources. Scores: CVS Health’s public earnings-call transcripts and SEC-reported results — the base band is anchored to reported GAAP revenue growth; transcript, EPS and guidance adjustments are applied separately (documented exceptions apply to a few issuers). Price: CVS daily closing prices for the trailing year; dots mark earnings calls, colored by that quarter’s score; the newest quarter’s score is part of Tellvest Pro. How to read a company earnings-call score.
The breakdown for this quarter is part of Tellvest Pro.
The table scrolls sideways. Swipe it, or select it and use the arrow keys.
| Quarter | Revenue | Rev YoY | EPS | EPS YoY | Gross margin | Op margin | Net margin | FCF |
|---|---|---|---|---|---|---|---|---|
| FY2024 Q4 | $97.71B | +4.2% | $1.30 | -18.2% | 13.2% | 2.4% | 1.7% | $1.09B |
| FY2025 Q1 | $94.59B | +7.0% | $1.41 | +60.2% | 15.2% | 3.6% | 1.9% | $3.81B |
| FY2025 Q2 | $98.92B | +8.4% | $0.80 | -43.3% | 13.7% | 2.4% | 1.0% | $1.29B |
| FY2025 Q3 | $102.87B | +7.8% | $-3.13 | -4629.7% | 13.4% | -3.1% | -3.9% | $98M |
| FY2025 Q4 | $105.69B | +8.2% | $2.30 | +76.9% | 12.8% | 2.0% | 2.8% | $2.61B |
| FY2026 Q1 | $100.43B | +6.2% | $2.30 | +63.1% | 15.6% | 4.7% | 2.9% | $3.40B |
| FY2026 Q2Selected | $106.10B | +7.3% | $2.31 | +188.8% | 14.8% | 4.4% | 2.8% | $5.65B |
Management-stated figures from CVS’s newest call are part of Tellvest Pro.
All prior quarters are free. How to browse earnings-call scores without Pro. How to read a company earnings-call score.
Full Pro access for 30 days when you create a free account. No credit card required.
No 8-K events recorded since this call day.